Physician profile
Janet E Maffei
NPI 1184813347
$1,715.78
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,186 · 2022: $414 · 2024: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $116.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $400.50 | 2021-2022 | |
| Abbvie INC. | $378.31 | 2021-2022 | |
| Lilly USA, LLC | $126.55 | 2021-2022 | |
| Olympus America INC. | $116.51 | 2024 | Itind System |
| Janssen Biotech, INC. | $100.03 | 2021 | |
| Pfizer INC. | $98.44 | 2021 | |
| Novartis Pharmaceuticals Corporation | $88.82 | 2021 | |
| Daiichi Sankyo INC. | $75.47 | 2021-2022 | |
| Glaxosmithkline, LLC. | $71.69 | 2021 | |
| Ucb, INC. | $57.58 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $46.79 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.44 | 2022 | |
| Genentech USA, INC. | $25.39 | 2021 | |
| Pacira Therapeutics, INC. | $18.69 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.76 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $14.36 | 2022 | |
| Eisai INC. | $14.18 | 2021 | |
| Horizon Therapeutics Plc | $14.15 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $14.09 | 2021 | |
| Abbott Laboratories | $13.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janet Maffei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.